         
|
|
|
|
1st appeared
17
October 2000
Institute of Medicine Adds Four from UCSF Four members of the UCSF campus were elected yesterday (October 16) to the prestigious Institute of Medicine: Elizabeth H. Blackburn, Thomas J. Coates, Deborah Greenspan, and Mary Anne Koda-Kimble. They were among 60 new members chosen for their major contributions to health and medicine or to related fields such as social and behavioral sciences, law, administration, and economics.
Election to the Institute of Medicine (IOM) is both an honor and an obligation to work on behalf of the organization in its governance and studies. With their election, members make a commitment to devote a significant amount of time as volunteers on committees engaged in a broad range of studies on health policy issues. Current IOM projects include studies on the creation of a medical system to support long-duration space travel beyond Earth's orbit, the development of new technologies for the early detection of breast cancer, and the safety and efficacy of the anthrax vaccine used by the US military. Links: |
||
|
DAYBREAK | ARCHIVES
| CALENDAR
| CAMPUS NOTES Copyright ©2000 Regents
of the University of California. All rights reserved. |
||
Elizabeth
H. Blackburn, PhD, a professor in the departments of biochemistry and
biophysics and of microbiology and immunology, has received numerous
honors for her pioneering work in the discovery of telomerase and its
potential role in cancer treatment and aging.
Thomas
J. Coates, PhD, professor of medicine and epidemiology, is also director
of the UCSF AIDS Research Institute and the Center for AIDS Prevention
Studies. An expert in disease-related behavior, he has been an international
leader in HIV prevention research and policy issues.
Deborah
Greenspan, DSc, professor of clinical oral medicine in the School of
Dentistry's department of stomatology, has led major clinical, laboratory,
and epidemiological studies relating to the oral manifestations of AIDS,
the oral effects of cancer therapy, and the development of new therapies
for oral mucosal and salivary gland disease. 
Mary
Anne Koda-Kimble, PharmD, is Dean of the School of Pharmacy; professor
of clinical pharmacy; and the Thomas J. Long Endowed Chair in Chain
Pharmacy Practice. She serves on the FDA's Nonprescription Drugs Advisory
Committee on the American Council of Pharmaceutical Education, a body
that accredits schools of pharmacy and continuing education programs
for pharmacists.